Moreover, studies have demonstrated that the interaction between the gut microbiota and inflammatory pathways, such as the NLRP3 inflammasome, plays a crucial role in MASLD and its progression. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.